In this study, we used NB4 cell lines and cells from a human patient with APL to investigate the ex vivo effects of ATRA and 25(OH)D3 cotreatment on NF-κB-regulated luciferase reporter gene activity. The gene discussed is NFKB1; the disease is acute promyelocytic leukemia.